BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22262183)

  • 1. TRIM8 modulates p53 activity to dictate cell cycle arrest.
    Caratozzolo MF; Micale L; Turturo MG; Cornacchia S; Fusco C; Marzano F; Augello B; D'Erchia AM; Guerrini L; Pesole G; Sbisà E; Merla G; Tullo A
    Cell Cycle; 2012 Feb; 11(3):511-23. PubMed ID: 22262183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells.
    Maarifi G; Smith N; Maillet S; Moncorgé O; Chamontin C; Edouard J; Sohm F; Blanchet FP; Herbeuval JP; Lutfalla G; Levraud JP; Arhel NJ; Nisole S
    Sci Adv; 2019 Nov; 5(11):eaax3511. PubMed ID: 31799391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor.
    Madan E; Gogna R; Bhatt M; Pati U; Kuppusamy P; Mahdi AA
    Oncotarget; 2011 Dec; 2(12):948-57. PubMed ID: 22248668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMG7 is a critical regulator of p53 stability and function in DNA damage stress response.
    Luo H; Cowen L; Yu G; Jiang W; Tang Y
    Cell Discov; 2016; 2():15042. PubMed ID: 27462439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the mouse double minute 4 gene causes changes in cell cycle control in a human mesothelial cell line responsive to ultraviolet radiation exposure.
    Bunderson-Schelvan M; Erbe AK; Schwanke C; Pershouse MA
    Environ Mol Mutagen; 2009 Dec; 50(9):753-9. PubMed ID: 19472317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.
    Carr MI; Jones SN
    Transl Cancer Res; 2016 Dec; 5(6):707-724. PubMed ID: 28690977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GADD45 proteins: central players in tumorigenesis.
    Tamura RE; de Vasconcellos JF; Sarkar D; Libermann TA; Fisher PB; Zerbini LF
    Curr Mol Med; 2012 Jun; 12(5):634-51. PubMed ID: 22515981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.
    Indeglia A; Murphy ME
    Crit Rev Biochem Mol Biol; 2024 Apr; ():1-11. PubMed ID: 38661126
    [No Abstract]   [Full Text] [Related]  

  • 9. 40 Years of Research Put p53 in Translation.
    Marcel V; Nguyen Van Long F; Diaz JJ
    Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29883412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the p53 family network by RNA-binding proteins.
    Lucchesi C; Zhang J; Chen X
    Transl Cancer Res; 2016 Dec; 5(6):676-684. PubMed ID: 28794999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Approaches for Upregulation of Tumor Suppressor Proteins: Pioneering Strategies and Integrative Potentials.
    Kargbo RB
    ACS Med Chem Lett; 2024 Jun; 15(6):761-762. PubMed ID: 38894916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-κB pathway.
    Tomar D; Sripada L; Prajapati P; Singh R; Singh AK; Singh R
    PLoS One; 2012; 7(11):e48662. PubMed ID: 23152791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.
    Caratozzolo MF; Valletti A; Gigante M; Aiello I; Mastropasqua F; Marzano F; Ditonno P; Carrieri G; Simonnet H; D'Erchia AM; Ranieri E; Pesole G; Sbisà E; Tullo A
    Oncotarget; 2014 Sep; 5(17):7446-57. PubMed ID: 25277184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling.
    Tian Z; Tang J; Liao X; Gong Y; Yang Q; Wu Y; Wu G
    Am J Cancer Res; 2020; 10(10):3440-3457. PubMed ID: 33163282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways.
    Venuto S; Castellana S; Monti M; Appolloni I; Fusilli C; Fusco C; Pucci P; Malatesta P; Mazza T; Merla G; Micale L
    Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):491-501. PubMed ID: 30528352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.
    Caratozzolo MF; Marzano F; Mastropasqua F; Sbisà E; Tullo A
    Genes (Basel); 2017 Nov; 8(12):. PubMed ID: 29182544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise of TRIM8: A Molecule of Duality.
    Bhaduri U; Merla G
    Mol Ther Nucleic Acids; 2020 Dec; 22():434-444. PubMed ID: 33230447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Roles of TRIM8 in Health and Disease.
    Marzano F; Guerrini L; Pesole G; Sbisà E; Tullo A
    Cells; 2021 Mar; 10(3):. PubMed ID: 33807506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.